Alexion Pharmaceuticals, Inc. (ALXN) · page 3 of 10
The slide uses a list of analyst quotes to frame the 'existential debate' and a table to quantify the impact of specific corporate missteps.
Shareholder letter · preempt_rebuttal · preempt_rebuttal · overcrowded density
Slide locked Sign in to view
Slide schematic 7/10
callout 0/1 list 2/2 metric 0/1 paragraph 3/3 quote 0/1 source-note 1/1 table 1/1
3 without position callout 1 · metric 1 · quote 1
calloutmetric · primaryquote
Components 10
callout bullet bullet primary paragraph paragraph paragraph quote source-note data
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1